Intermittent claudication and quality of life. Psychometric validation of the French version of the CLAU-S questionnaire;Claudication intermittente et qualite de vie. Validation des qualites psychometriques de la version francaise du questionnaire CLAU-S

Journal des Maladies Vasculaires

Volumn 25, Issue 2, 2000, Pages 98-107

  Boccalon, H ^a   Lehert, P ^c   Comte, S ^b  

^a CHU RANGUEIL   (France)

^b Groupe Lipha   (France)

^c NONE

Author keywords

CLAU S ('Claudication Scale'); Intermittent claudication; Peripheral arterial occlusive disease; Psychometric validation; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; ANXIETY; CLINICAL TRIAL; DAILY LIFE ACTIVITY; EVALUATION; FEMALE; FRANCE; HOSPITALIZATION; LANGUAGE; MALE; MIDDLE AGED; MOOD DISORDER; MULTICENTER STUDY; PAIN; PSYCHOLOGICAL ASPECT; REPRODUCIBILITY; SOCIAL PROBLEM; WALKING;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; EVALUATION STUDIES; FEMALE; FRANCE; HUMANS; INTERMITTENT CLAUDICATION; LANGUAGE; MALE; MIDDLE AGED; MOOD DISORDERS; PAIN; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SOCIAL PROBLEMS; WALKING;

EID: 0034167090     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BARLETTA G, PEISSA S, SABBA C, CATALANIO M, O'BOYLE C, BREVETTI G. Quality of life in patients with intermittent claudication : relationship with laboratory exercise performance. Vasc Med, 1996 ; 1 : 3-8.
2. BOCCALON H. Intermittent Claudication in Older Patients. Practical Treatment Guidelines. Drugs & Aging, 1999 ; 14: 247-59.
3. BOLLEN KA. Structural equations with latent variables. J Wiley New York, 1989.
4. BRIANÇON S, ALLA F, MÉJAT E, et al. Mesure de l'incapacité fonctionnelle et de la qualité de vie dans l'insuffisance cardiaque. Adaptation transculturelle et validation des questionnaires de Goldman, du Minesota et de Duke. Arch Mal Cœur, 1997 ; 90 : 1577-85.
5. CAMPBELL D, FISK DW. Convergent and discriminant validation by the multitrait multimethod matrix. Psychological bulletin, 1959 ; 56 : 85-105.
6. CREUTZIG A, BLLLINGER M, CACHOVAN M, DIEHM C, FORST HT, GRUß JD, HORSCH S, ROGATTI W, SCHEFFER P, SPENGEL F, STIEGLER H. Improvement in the quality of life after IV PGEI therapy for intermittent claudication. VASA, 1997 ; 26 : 122-7.
7. CRIQUI MH, FRONEK A, BARRET-CONNOR E, KLAUBER MR, GABRIEL S, GOODMAN D. The prevalence of peripheral arterial disease in a defined population. Circulation, 1985 ; 71 : 510-5.
8. CRIQUI MH, LANGER RD, FRONEK A, FEIGELSON HS, KLAUBER MR, MCCANN TJ, BROWNER D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med, 1992 ; 326 : 38-46.
9. CRONBACH L. Coefficient Alpha and the Internal Structure of tests. Psychometrica, 1951 ; 16 : 297-324.
10. DEYO R, DIEHR P, PATRICK D. Reproducibility and Responsiveness of Health Status Measures : Statistics and Strategies for Evaluation. Controlled Clinical Trials, 1991 ; 12 : 142S-158S.
11. DIETZE S, KIRCHBERGER I, SPENGEL F, VAN LAAK H, COMTE S. The Claudication scale (CLAU-S) a disease specific questionnaire for the assessment of the quality of life in patients with intermittent claudication : Development and validation. Gefäßchirurgie 1997 ; 2 : 11-7.
12. FLEISS J, COHEN J. The Equivalence of Weighted Kapa and the Intraclass Correlation Coefficient as Measures of Reliability. Educational and Psychological Measurement. 1973 ; 33 : 613-9.
13. GARDNER AW, WOMACK CJ, SIEMINSKI DJ, MONTGOMERY PS, KILLEWICH LA, FONONG T. Relationship between free-living daily physical activity and ambulatory measures in older claudicants. Angiology, 1998 ; 49 : 327-37.
14. LIARD F, BÉNICHOU AC. GAMAND S, LEHERT P. Les effets du naftidrofuryl sur la qualité de vie. Dis Manage Health outcomes, 1997 ; 2 Suppl. 1 : 71-8.
15. LOEHLIN JC. Latent variable model. 2nd edition. Lawrence Erlbaum Associates Hillsdale, New Jersey 1992.
16. LORD FM, NOVICK MR. Statistical theories of mental tests scores. Reading MA : Addison & Wesley, 1968.
17. MARQUIS P, FAYOL C, MCCARTHY C, FIESSINGER JN. Mesure de la qualité de vie dans la claudication intermittente. Validation clinique d'un questionnaire. Presse Med, 1994 ; 23 : 1288-92.
18. rd edition. 1994.
19. PONTE E, CATTINELLI S. Quality of Life in a group of patients with intermittent claudication. J Vasc Dis, 1996 ; 47 : 247-51.
20. SCHIPPER H, CLINCH J, POWELL V. Definitions and conceptual issues. In : Spilker B ed. Quality of life assessments in clinical trials. New York : Raven Press, 1990 ; 2 : 11-24.
21. SMITH GD, SHIPLEY MJ, ROSE G. Intermittent claudication, heart disease risk factors, and mortality. Circulation, 1990 ; 6 : 1925-31.
22. SPENGEL F, BROWN TM, POTH J, LEHERT P. Naftidrofuryl can enhance the quality of life in patients with intermittent claudication. VASA 1999 ; 28 : 207-12.
23. SPENGEL FA, BROWN TM, DIETZE S, KIRCHBERGER I, COMTE S. The claudication scale (CLAU-S) : a new disease-specific quality of life instrument in intermittent claudication. Dis Manage Health outcomes, 1997 ; 2 Suppl. 1 : 65-70.
24. SPENGHL FA, LEHERT P, DIETZE S. A statistical consideration of CLAU-S : a disease specific questionnaire for the assessment of quality of life in patients with intermittent claudication. VASA, 1998 ; 27 : 253.
25. The European Agency for the Evaluation of Medicinal products. Human Medicines Evaluation Unit. Note for guidance on the chronic peripheral arterial occlusive disease. CPMP Efficacy Working Parly - November 1995.
26. WARE JE. SF-36, Health Survey. Manual and interpretation guide. Boston, Mass : the Health Institute, 1993 ; 25-40.
27. WILSON A, WIKLUND I, LAHTI T, WAHL M. A summary index for the assessment of quality of life in angina pectoris. J Clin Epidemiol, 1991 ; 44 : 981-8.